Dashboard
- All
-
Following
You must log in
before getting
tailored content. -
Interests
You must log in
before getting
tailored content. - Most liked
- Most viewed
Directory:
Tags:
|
In October 2014 Harvard professor Douglas Melton announced a breakthrough in the treatment of type-1 diabetes by creating stem cells that produce insulin.
Melton demonstrated that mice treated with transplanted pancreatic cells are still producing insulin months after being injected. Testing in primates is now underway at the University of Chicago, and clinical studies in humans should begin in just a few years. "Most patients are sick of hearing that something's just around the corner," says Melton, but he's convinced that his research represents a significant turning point in the fight against diabetes. Type-1 Type-1 diabetes, which usually occurs in children, is an autoimmune disease in which the body attacks its own beta cells of the pancreas and destroys their ability to make insulin. It's a devastating lifelong chronic condition, which affects some three million Americans and 400,000 English people. Treatment is daily insulin doses, a healthy diet and regular physical activity. |
|
|
Directory:
Tags:
Tanja Schomann
eHealth ResearcherI'm currently working on my PhD dissertation at Cambridge University. My PhD is about trust on the internet. My main research questions are: How do people decide whether or not to trust a service provider on the internet? Which are the key signals that people are looking for? How good are we at determining the trustworthiness of others on the internet? My work is supervised by Dr. David Good and Dr. Alan Blackwell.
I'm collaborating with a German ehealth company called Medexo. Medexo provides medical second opinions on the internet. They cover the German market only.
view this profile
1 comment